Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Predicting 15-year prostate cancer specific mortality after radical prostatectomy.
Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, Feng Z, Wood DP, Eastham JA, Yossepowitch O, Rabah DM, Kattan MW, Yu C, Klein EA, Stephenson AJ.
J Urol. 2011 Mar;185(3):869-75. doi: 10.1016/j.juro.2010.10.057. Epub 2011 Jan 15.
Similar articles
Predicting 6-year mortality risk in patients with type 2 diabetes.
Wells BJ, Jain A, Arrigain S, Yu C, Rosenkrans WA Jr, Kattan MW.
Diabetes Care. 2008 Dec;31(12):2301-6. doi: 10.2337/dc08-1047. Epub 2008 Sep 22.
Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer.
Kattan MW, Vickers AJ, Yu C, Bianco FJ, Cronin AM, Eastham JA, Klein EA, Reuther AM, Edson Pontes J, Scardino PT.
Cancer. 2009 Mar 1;115(5):1005-10. doi: 10.1002/cncr.24083.
Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable.
Potters L, Roach M 3rd, Davis BJ, Stock RG, Ciezki JP, Zelefsky MJ, Stone NN, Fearn PA, Yu C, Shinohara K, Kattan MW.
Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1061-5. doi: 10.1016/j.ijrobp.2009.03.031. Epub 2009 Jun 18.
A nomogram for predicting upgrading in patients with low- and intermediate-grade prostate cancer in the era of extended prostate sampling.
Moussa AS, Kattan MW, Berglund R, Yu C, Fareed K, Jones JS.
BJU Int. 2010 Feb;105(3):352-8. doi: 10.1111/j.1464-410X.2009.08778.x. Epub 2009 Aug 13.
Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy.
Nguyen CT, Yu C, Moussa A, Kattan MW, Jones JS.
J Urol. 2010 Feb;183(2):529-33. doi: 10.1016/j.juro.2009.10.007. Epub 2009 Dec 14.
Development and internal validation of a nomogram predicting extracapsular extension in radical prostatectomy specimens.
Satake N, Ohori M, Yu C, Kattan MW, Ohno Y, Miyakawa A, Hatano T, Tachibana M.
Int J Urol. 2010 Mar;17(3):267-72. doi: 10.1111/j.1442-2042.2010.02452.x. Epub 2010 Feb 3.
The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.
Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A, Atreja A, Zimmerman RS.
Diabetes Care. 2010 Jun;33(6):1224-9. doi: 10.2337/dc10-0017. Epub 2010 Mar 9.
Nomogram to predict seminal vesicle invasion using the status of cancer at the base of the prostate on systematic biopsy.
Ohori M, Kattan MW, Yu C, Matsumoto K, Satoh T, Ishii J, Miyakawa A, Irie A, Iwamura M, Tachibana M.
Int J Urol. 2010 Jun;17(6):534-40. doi: 10.1111/j.1442-2042.2010.02513.x. Epub 2010 Mar 29.
Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling.
Moussa AS, Jones JS, Yu C, Fareed K, Kattan MW.
BJU Int. 2010 Nov;106(9):1309-14. doi: 10.1111/j.1464-410X.2010.09362.x.
Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases.
Reddy SK, Kattan MW, Yu C, Ceppa EP, de la Fuente SG, Fong Y, Clary BM, White RR.
HPB (Oxford). 2009 Nov;11(7):592-9. doi: 10.1111/j.1477-2574.2009.00106.x.
Comparative 5-year outcomes of brachytherapy and surgery for prostate cancer.
Pickles T, Morris WJ, Kattan MW, Yu C, Keyes M.
Brachytherapy. 2011 Jan-Feb;10(1):9-14. doi: 10.1016/j.brachy.2009.12.004.
Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer.
Lee MC, Moussa AS, Yu C, Kattan MW, Magi-Galluzzi C, Jones JS.
J Urol. 2010 Nov;184(5):1958-62. doi: 10.1016/j.juro.2010.06.137. Epub 2010 Sep 17.
Development and validation of preoperative nomogram for disease recurrence within 5 years after laparoscopic radical prostatectomy for prostate cancer.
Kattan MW, Yu C, Salomon L, Vora K, Touijer K, Guillonneau B.
Urology. 2011 Feb;77(2):396-401. doi: 10.1016/j.urology.2010.05.013. Epub 2010 Oct 23.
Nomogram for predicting malignancy in thyroid nodules using clinical, biochemical, ultrasonographic, and cytologic features.
Nixon IJ, Ganly I, Hann LE, Lin O, Yu C, Brandt S, Shah JP, Shaha A, Kattan MW, Patel SG.
Surgery. 2010 Dec;148(6):1120-7; discussion 1127-8. doi: 10.1016/j.surg.2010.09.030.
An empirical approach to model selection through validation for censored survival data.
Choi I, Wells BJ, Yu C, Kattan MW.
J Biomed Inform. 2011 Aug;44(4):595-606. doi: 10.1016/j.jbi.2011.02.005. Epub 2011 Feb 16.
Validation of postoperative nomograms in prostate cancer patients with long-term follow-up.
Swanson GP, Yu C, Kattan MW, Hermans MR.
Urology. 2011 Jul;78(1):105-9. doi: 10.1016/j.urology.2011.01.061. Epub 2011 Apr 19.
Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome.
Valdagni R, Kattan MW, Rancati T, Yu C, Vavassori V, Fellin G, Cagna E, Gabriele P, Mauro FA, Baccolini M, Bianchi C, Menegotti L, Monti AF, Stasi M, Giganti MO, Fiorino C.
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1957-66. doi: 10.1016/j.ijrobp.2011.03.028. Epub 2011 Jun 2.
Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators.
Nam RK, Kattan MW, Chin JL, Trachtenberg J, Singal R, Rendon R, Klotz LH, Sugar L, Sherman C, Izawa J, Bell D, Stanimirovic A, Venkateswaran V, Diamandis EP, Yu C, Loblaw DA, Narod SA.
J Clin Oncol. 2011 Aug 1;29(22):2959-64. doi: 10.1200/JCO.2010.32.6371. Epub 2011 Jun 20.
Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information.
Zaytoun OM, Kattan MW, Moussa AS, Li J, Yu C, Jones JS.
Urology. 2011 Aug;78(2):392-8. doi: 10.1016/j.urology.2011.04.042. Epub 2011 Jun 25.
Filters: Manage Filters